NEMAURA MED INC's ticker is NMRD and the CUSIP is 640442208. A total of 15 filers reported holding NEMAURA MED INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,323 | -65.3% | 53,666 | 0.0% | 0.00% | – |
| Q2 2023 | $49,899 | +6.3% | 53,666 | 0.0% | 0.00% | – |
| Q1 2023 | $46,958 | -61.2% | 53,666 | -24.7% | 0.00% | – |
| Q4 2022 | $121,122 | +63.7% | 71,248 | +100.0% | 0.00% | – |
| Q3 2022 | $74,000 | -19.6% | 35,624 | 0.0% | 0.00% | – |
| Q2 2022 | $92,000 | -41.0% | 35,624 | 0.0% | 0.00% | – |
| Q1 2022 | $156,000 | +4.7% | 35,624 | +9.0% | 0.00% | – |
| Q4 2021 | $149,000 | -69.8% | 32,689 | -60.1% | 0.00% | – |
| Q3 2021 | $493,000 | -53.4% | 81,947 | -19.8% | 0.00% | – |
| Q2 2021 | $1,058,000 | +30.6% | 102,189 | -3.6% | 0.00% | – |
| Q1 2021 | $810,000 | +233.3% | 105,981 | +64.6% | 0.00% | – |
| Q4 2020 | $243,000 | +2.5% | 64,381 | -3.7% | 0.00% | – |
| Q3 2020 | $237,000 | -62.3% | 66,881 | -1.6% | 0.00% | – |
| Q2 2020 | $629,000 | – | 67,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 2,483,271 | $2,297,274 | 0.02% |
| VANGUARD GROUP INC | 130,861 | $121,060 | 0.00% |
| UBS Group AG | 170 | $158 | 0.00% |
| NewEdge Advisors, LLC | 360 | $333 | 0.00% |
| HAZLETT, BURT & WATSON, INC. | 30 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,156 | $3,844 | 0.00% |
| NORTHERN TRUST CORP | 26,737 | $24,734 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 107,897 | $100,322 | 0.00% |
| STATE STREET CORP | 53,666 | $49,899 | 0.00% |